Sustained immune tolerance induction in enzyme replacement therapy–treated CRIM-negative patients with infantile Pompe disease

Zoheb B. Kazi(Duke Medical Center), Priya S. Kishnani(Duke Medical Center), Punita Gupta(St. Joseph’s University Medical Center), Pranoot Tanpaiboon(Children's National), Raymond Wang(Children's Hospital of Orange County), Nancy J. Mendelsohn, Kathryn L. Berrier(Duke Medical Center), Michelle Polan(Akron Children's Hospital), R. Bradley Troxler(University of Alabama at Birmingham), Ankit K. Desai(Duke Medical Center), Michal Inbar‐Feigenberg(University of Toronto), Omar Abdul‐Rahman(Cornell University), Amy S. Rosenberg(Center for Drug Evaluation and Research), Catherine Ward‐Melver(Akron Children's Hospital), David Kronn(New York Medical College), Eli Herskovitz(Soroka Medical Center)
JCI Insight
August 16, 2017
Cited by 72


Related Papers